2. Φάρμακα Παθήσεων Κυκλοφορικού Συστήματος
2.8 Αντιπηκτικά
2.8.1 Παρεντερικά αντιπηκτικά
 |
|
| | |
|
| | |
|
ID | Pharmaceutical product | ATC Code | Unit | Unit Size | Price level indicator | Route of Administration | Restrictions |
1000693 | Heparin Low Molec Weight 4000 I.U. inj | B01AB | Syringe / Vials | 1 | II | Parenteral | |
1000682 | Heparin Low Molec Weight 2000 I.U. inj | B01AB | Syringe / Vials | 1 | II | Parenteral | |
1000745 | Heparinised Saline 50 U inj | B01AB01 | Amp/Vial | 1 | I | Parenteral | |
1000663 | Heparin Sodium 25000 I.U. inj | B01AB01 | Amp/Vial | 1 | II | Parenteral | |
1001865 | Dalteparin Sodium 10000 I.U. inj | B01AB04 | Syringe / Vials | 1 | II | Parenteral | |
1001911 | Dalteparin Sodium 2500 I.U. inj | B01AB04 | Syringe / Vials | 1 | I | Parenteral | |
1001912 | Dalteparin Sodium 5000 I.U. inj | B01AB04 | Syringe / Vials | 1 | II | Parenteral | |
1000695 | Heparin Low Molec Weight 8000 I.U. inj | B01AB05 | Syringe / Vials | 1 | II | Parenteral | |
1000141 | Nadroparin Calcium 5700 I.U.AXa inj | B01AB06 | Syringe / Vials | 1 | II | Parenteral | |
1002613 | Nadroparin Calcium 3800 I.U.AXa inj | B01AB06 | Syringe / Vials | 1 | I | Parenteral | |
1002614 | Nadroparin Calcium 2850 I.U.AXa inj | B01AB06 | Syringe / Vials | 1 | I | Parenteral | |
1002615 | Nadroparin Calcium 7600 I.U.AXa inj | B01AB06 | Syringe / Vials | 1 | II | Parenteral | |
1000041 | Epoprostenol 500mcg inj | B01AC09 | Amp/Vial | 1 | VI | Parenteral | |
1000093 | Fondaparinux Sodium 5mg inj | B01AX05 | Syringe / Vials | 1 | IV | Parenteral | ΠΕΡΙΟΡΙΣΜΟΙ ΒΑΣΕΙ ΙΑΤΡ.ΕΙΔΙΚ. |
1002370 | Fondaparinux Sodium 7,5mg inj | B01AX05 | Syringe / Vials | 1 | IV | Parenteral | ΠΕΡΙΟΡΙΣΜΟΙ ΒΑΣΕΙ ΙΑΤΡ.ΕΙΔΙΚ. |
1000147 | Fondaparinux 10mg inj | B01AX05 | Syringe / Vials | 1 | IV | Parenteral | ΠΕΡΙΟΡΙΣΜΟΙ ΒΑΣΕΙ ΙΑΤΡ.ΕΙΔΙΚ. |
1000148 | Fondaparinux 2,5mg inj | B01AX05 | Syringe / Vials | 1 | II | Parenteral | ΠΕΡΙΟΡΙΣΜΟΙ ΒΑΣΕΙ ΙΑΤΡ.ΕΙΔΙΚ. |
|
|
No documents found